1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Lung Cancer Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Lung Cancer Surgery Market, by Procedure Type
8.1.1. Lobectomy
8.1.1.1. Market Revenue and Forecast
8.1.2. Segmentectomy
8.1.2.1. Market Revenue and Forecast
8.1.3. Pneumonectomy
8.1.3.1. Market Revenue and Forecast
8.1.4. Other
8.1.4.1. Market Revenue and Forecast
9.1. Lung Cancer Surgery Market, by Surgical Approach Type
9.1.1. Open surgery
9.1.1.1. Market Revenue and Forecast
9.1.2. Video-assisted thoracoscopic surgery (VATS)
9.1.2.1. Market Revenue and Forecast
9.1.3. Robotic-assisted thoracic surgery (RATS)
9.1.3.1. Market Revenue and Forecast
10.1. Lung Cancer Surgery Market, by Cancer Type
10.1.1. Non-small cell lung cancer (NSCLC)
10.1.1.1. Market Revenue and Forecast
10.1.2. Small cell lung cancer (SCLC)
10.1.2.1. Market Revenue and Forecast
11.1. Lung Cancer Surgery Market, by Provider Type
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Cancer care centers
11.1.2.1. Market Revenue and Forecast
11.1.3. Other
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Procedure Type
12.1.2. Market Revenue and Forecast, by Surgical Approach Type
12.1.3. Market Revenue and Forecast, by Cancer Type
12.1.4. Market Revenue and Forecast, by Provider Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Procedure Type
12.1.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.1.5.3. Market Revenue and Forecast, by Cancer Type
12.1.5.4. Market Revenue and Forecast, by Provider Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Procedure Type
12.1.6.2. Market Revenue and Forecast, by Surgical Approach Type
12.1.6.3. Market Revenue and Forecast, by Cancer Type
12.1.6.4. Market Revenue and Forecast, by Provider Type
12.2. Europe
12.2.1. Market Revenue and Forecast, by Procedure Type
12.2.2. Market Revenue and Forecast, by Surgical Approach Type
12.2.3. Market Revenue and Forecast, by Cancer Type
12.2.4. Market Revenue and Forecast, by Provider Type
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Procedure Type
12.2.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.2.5.3. Market Revenue and Forecast, by Cancer Type
12.2.5.4. Market Revenue and Forecast, by Provider Type
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Procedure Type
12.2.6.2. Market Revenue and Forecast, by Surgical Approach Type
12.2.6.3. Market Revenue and Forecast, by Cancer Type
12.2.6.4. Market Revenue and Forecast, by Provider Type
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Procedure Type
12.2.7.2. Market Revenue and Forecast, by Surgical Approach Type
12.2.7.3. Market Revenue and Forecast, by Cancer Type
12.2.7.4. Market Revenue and Forecast, by Provider Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Procedure Type
12.2.8.2. Market Revenue and Forecast, by Surgical Approach Type
12.2.8.3. Market Revenue and Forecast, by Cancer Type
12.2.8.4. Market Revenue and Forecast, by Provider Type
12.3. APAC
12.3.1. Market Revenue and Forecast, by Procedure Type
12.3.2. Market Revenue and Forecast, by Surgical Approach Type
12.3.3. Market Revenue and Forecast, by Cancer Type
12.3.4. Market Revenue and Forecast, by Provider Type
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Procedure Type
12.3.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.3.5.3. Market Revenue and Forecast, by Cancer Type
12.3.5.4. Market Revenue and Forecast, by Provider Type
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Procedure Type
12.3.6.2. Market Revenue and Forecast, by Surgical Approach Type
12.3.6.3. Market Revenue and Forecast, by Cancer Type
12.3.6.4. Market Revenue and Forecast, by Provider Type
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Procedure Type
12.3.7.2. Market Revenue and Forecast, by Surgical Approach Type
12.3.7.3. Market Revenue and Forecast, by Cancer Type
12.3.7.4. Market Revenue and Forecast, by Provider Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Procedure Type
12.3.8.2. Market Revenue and Forecast, by Surgical Approach Type
12.3.8.3. Market Revenue and Forecast, by Cancer Type
12.3.8.4. Market Revenue and Forecast, by Provider Type
12.4. MEA
12.4.1. Market Revenue and Forecast, by Procedure Type
12.4.2. Market Revenue and Forecast, by Surgical Approach Type
12.4.3. Market Revenue and Forecast, by Cancer Type
12.4.4. Market Revenue and Forecast, by Provider Type
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Procedure Type
12.4.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.4.5.3. Market Revenue and Forecast, by Cancer Type
12.4.5.4. Market Revenue and Forecast, by Provider Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Procedure Type
12.4.6.2. Market Revenue and Forecast, by Surgical Approach Type
12.4.6.3. Market Revenue and Forecast, by Cancer Type
12.4.6.4. Market Revenue and Forecast, by Provider Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Procedure Type
12.4.7.2. Market Revenue and Forecast, by Surgical Approach Type
12.4.7.3. Market Revenue and Forecast, by Cancer Type
12.4.7.4. Market Revenue and Forecast, by Provider Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Procedure Type
12.4.8.2. Market Revenue and Forecast, by Surgical Approach Type
12.4.8.3. Market Revenue and Forecast, by Cancer Type
12.4.8.4. Market Revenue and Forecast, by Provider Type
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Procedure Type
12.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.5.3. Market Revenue and Forecast, by Cancer Type
12.5.4. Market Revenue and Forecast, by Provider Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Procedure Type
12.5.5.2. Market Revenue and Forecast, by Surgical Approach Type
12.5.5.3. Market Revenue and Forecast, by Cancer Type
12.5.5.4. Market Revenue and Forecast, by Provider Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Procedure Type
12.5.6.2. Market Revenue and Forecast, by Surgical Approach Type
12.5.6.3. Market Revenue and Forecast, by Cancer Type
12.5.6.4. Market Revenue and Forecast, by Provider Type
13.1. Johnson & Johnson (Ethicon LLC)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic Plc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Intuitive Surgical Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Olympus Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Karl Storz SE & Co. KG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Accuray Incorporated
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Teleflex Incorporated
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. B. Braun Melsungen AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. AngioDynamics Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
